³Ô¹ÏÍøÕ¾

Latest

Latest Vanderbilt University News

  • Latest Vanderbilt University news stories and updates. What is happening today? All recent Vanderbilt University news and developments. Live coverage and timeline of Vanderbilt University. All you need to know about Vanderbilt University.
Doctors are preoccupied with threats of criminal charges in states with abortion bans, putting patients’ lives at risk
Things to do: Halloween movies, Canine Crawl, election insights
Researchers discovered mechanism driving immune perturbations after severe infections
World-first tool to predict risk of sudden cardiac arrest
How we discovered that people who are colorblind are less likely to be picky eaters
NIH Funds Consortium To Speed TB Treatment Development
Was Beethoven Unmusical?
Getting a good night’s rest is vital for neurodiverse children – pediatric sleep experts explain why
Dr. Mary Dickinson named a 2023 Fellow by the American Association for the Advancement of Science
AI chatbots refuse to produce ‘controversial’ output − why that’s a free speech problem
Worried about housing shortages and soaring prices? Your community’s zoning laws could be part of the problem
Leading US Cardiologist Visits Heart Research Institute
Family caregivers can help shape the outcomes for their loved ones – an ICU nurse explains their vital role
New consortium of healthcare leaders announces formation of Trustworthy & Responsible AI Network (TRAIN), making safe and fair AI accessible to every healthcare organization
Could the days of ‘springing forward’ be numbered? A neurologist and sleep expert explains the downside to that borrowed hour of daylight
How to create safe spaces with and for Black girls
Autopen shows perils of automation in communications
Immune protein may induce dementia unrelated to high blood pressure
Choice of intravenous fluid therapy could improve survival in critically ill patients
Material Would Allow Users to ‘Tune’ Windows to Block Targeted Wavelengths of Light
Qantas announces board changes
Delivering on the promise of personalized breast cancer therapy
ECCMID data reinforces AstraZeneca’s commitment to transform protection for the most vulnerable by advancing science in vaccines and immune therapies
Four UWA high achievers awarded Fulbright Scholarships
Hummingbird flight could provide insights for biomimicry in aerial vehicles
Novel atlas shows vast urban infrastructure divide between Global South and Global North
IDWeek data reinforces AstraZeneca’s commitment to advance science in vaccines and immune therapies
Scientists propose obesity is neurodevelopmental disorder
Millions of Australians still haven’t had their COVID boosters
Alterity Therapeutics announces poster presentation from major study
Evusheld long-acting antibody combination approved in EU for treatment of Covid
Evusheld long-acting antibody combination recommended for approval in EU for treatment of Covid
YouTube More Likely to Direct Election-Fraud Videos to Users Already Skeptical about 2020 Election’s Legitimacy
Evusheld long-acting antibody combination approved for prevention and treatment of Covid in Japan
Researchers identify how cells move faster through mucus than blood
Australian Discovery in Sudden Cardiac Arrest Could Save Lives
Evusheld significantly prevented Covid disease progression or death in TACKLE Phase III treatment trial
Links between incentives and ethical lapses identified in ILR research
Evusheld significantly protected against symptomatic Covid for
Evusheld long-acting antibody combination approved in EU for pre-exposure prophylaxis of Covid in broad population
Evusheld long-acting antibody combination recommended for approval in EU for pre-exposure prophylaxis of Covid
AstraZeneca’s antibody combination, Evusheldâ–¼ authorised for use
Researchers founding scientists of new GPCR biotechnology company launched with AUD$140 million in financing
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant 23 December
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant
Evusheld long-acting antibody combination authorised for emergency use
New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
AZD7442 reduced risk of developing severe Covid or death in TACKLE Phase III outpatient treatment trial

© 2024 - ³Ô¹ÏÍøÕ¾